Cannabinoid Drugs Market Expected to Grow at a Steady Pace from 2023 to 2028: Trends and Forecast


Published April 5, 2023

Cannabinoid Drugs are natural occurring recreational drugs used to treat anorexia, chronic pain, and nausea & vomiting. The cannabinoid is used for a group of drugs that are structurally related to tetrahydro cannabinoids. It is manufactured by pharma companies to treat different indications, such as multiple chronic & acute migraine, sclerosis, seizures, rheumatoid arthritis, etc.

Grab PDF to Know More (Including Table, Full TOC and Figures) @  

The Cannabinoid Drugs market is expected to grow significantly in the coming years, due to Rising demand for cannabinoid drugs for treating chronic pain in different indications. Moreover, healthcare expenditure in field of dermatology supported by FDA approvals anticipated to influence the end-user of Cannabinoid Drugs .

The report also includes the profiles of key players in Cannabinoid Drugs market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

Top Key Players:-

  • Canopy Growth Corporation
  • Aurora Cannabis Inc.
  • Tikun Olam
  • Cannabis Science Inc.
  • Aphria Inc.
  • Maricann Group Inc.
  • Tilray Inc.
  • VIVO Cannabis Inc.
  • Medical Marijuana, Inc.
  • STENOCARE and Others

Speak to Analyst for more details:  

Global Cannabinoid Drugs Market 2023 Research Report initially provides a basic overview of the industry that covers definition, applications and manufacturing technology, post which the report explores into the international players in the market.


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Cannabinoid Drugs market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Cannabinoid Drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting cannabinoid drugs market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Cannabinoid Drugs market in these regions.

Directly Purchase Premium Copy of Cannabinoid Drugs Market Growth Report:

About US

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Food and Beverages, Consumers and Goods, Chemicals and Materials.

Contact US

Contact Person : Sameer Joshi .

Phone : +1-646-491-9876

E-mail : [email protected]

Read more here: Source link

Leave a Reply

Your email address will not be published. Required fields are marked *